Welldoc

Welldoc is a global digital health platform based in Columbia, Maryland, founded in 2005.

The company focuses on chronic condition management using clinically validated artificial intelligence and automated patient coaching. Welldoc aims to connect fragmented healthcare through its innovative technology, enhancing care delivery. The flagship product, BlueStar, is an FDA-cleared mobile prescription therapy specifically designed for Type 2 diabetes. It offers real-time coaching and support for self-management, requiring a prescription from a healthcare provider. In addition to diabetes, Welldoc's platform supports various conditions, including pre-diabetes, hypertension, heart failure, and mental wellbeing. The platform provides personalized insights and decision support for care teams, making it a valuable tool for both patients and healthcare providers. Welldoc collaborates with health plans, hospitals, employers, and life science companies to improve health outcomes and reduce costs. With over 100 peer-reviewed publications and 60 patents, Welldoc is committed to advancing healthcare through its AI-driven solutions.